Relations of disease-free survival and overall survival with age and primary metastases in patients with breast cancer

Journal of Isfahan Medical School

Volumn 31, Issue 225, 2013, Pages

  Mokarian, Fariborz ^a   Mokarian, Shirin ^a   Ramezani, Arash ^b  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Age; Breast cancer; Disease manifestation; Disease free survival; Overall survival

Indexed keywords

ADULT; AGE; ARTICLE; BREAST CANCER; DISEASE FREE SURVIVAL; FEMALE; HUMAN; METASTASIS; MIDDLE AGED; OVERALL SURVIVAL; RETROSPECTIVE STUDY; SCREENING;

EID: 84940324379     PISSN: 10277595     EISSN: 1735854X     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Costanza ME, Chen WY. Factors that modify breast cancer risk in women. Up to Date [Online]. 2012. Available from: URL: http://www.uptodate.com/contents/factors-thatmodify-breast-cancer-risk-in-women
2. Harlow SP, Weaver L. Management of the regional lymph nodes in breast cancer [Online]. 2012. Available from: URL: http://www.uptodate.com/contents/management-of-the-regional-lymph-nodes-in-breast-cancer.
3. Fletcher S. Screening for breast cancer. UpToDate [Online]. 2012. Available from: URL: http://www.uptodate.com/contents/screening-for-breast-cancer
4. Sirous M, Ebrahimi A. The epidemiology of breast masses among women in Isfahan. Iran J Surg 2008; 16(3): 51-6.
5. Natarajan L, Pu M, Parker BA, Thomson CA, Caan BJ, Flatt SW, et al. Time-varying effects of prognostic factors associated with diseasefree survival in breast cancer. Am J Epidemiol 2009; 169(12): 463-70.
6. Montero JC, Ocana A, Abad M, Ortiz-Ruiz MJ, Pandiella A, Esparis-Ogando A. Expression of Erk5 in early stage breast cancer and association with disease free survival identifies this kinase as a potential therapeutic target. PLoS One 2009; 4(5): e5565.
7. Lin NU, Claus E, Sohl J, Razzak AR, Arnaout A, Winer EP. Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases. Cancer 2008; 113(10): 2638-45.
8. Dabakuyo TS, Bonnetain F, Roignot P, Poillot ML, Chaplain G, Altwegg T, et al. Populationbased study of breast cancer survival in Cote d'Or (France): prognostic factors and relative survival. Ann Oncol 2008; 19(2): 276-83.
9. Blancas I, Garcia-Puche JL, Bermejo B, Hanrahan EO, Monteagudo C, Martinez-Agullo A, et al. Low number of examined lymph nodes in node-negative breast cancer patients is an adverse prognostic factor. Ann Oncol 2006; 17(11): 1644-9.
10. Querzoli P, Pedriali M, Rinaldi R, Lombardi AR, Biganzoli E, Boracchi P, et al. Axillary lymph node nanometastases are prognostic factors for disease-free survival and metastatic relapse in breast cancer patients. Clin Cancer Res 2006; 12(22): 6696-701.
11. Kaklamani V, Gradishar J. Axillary node metastases with occult primary breast cancer. UpToDate [Online]. 2012. Available from: URL: http://www.uptodate.com/contents/axillary-node-metastases-with-occult-primarybreast-cancer.
12. Blancas I, Garcia-Puche JL, Bermejo B, Hanrahan EO, Monteagudo C, Martinez-Agullo A, et al. Low number of examined lymph nodes in node-negative breast cancer patients is an adverse prognostic factor. Ann Oncol 2006; 17(11): 1644-9.
13. Jayasinghe UW, Taylor R, Boyages J. Is age at diagnosis an independent prognostic factor for survival following breast cancer? ANZ J Surg 2005; 75(9): 762-7.
14. Lundin J, Lehtimaki T, Lundin M, Holli K, Elomaa L, Turpeenniemi-Hujanen T, et al. Generalisability of survival estimates for patients with breast cancer--a comparison across two population-based series. Eur J Cancer 2006; 42(18): 3228-35.
15. Farooq S, Coleman MP. Breast cancer survival in South Asian women in England and Wales. J Epidemiol Community Health 2005; 59(5): 402-6.
16. Gokce T, Karadogan I, Akçay C. A long-term survival pattern for breast cancer treated in a single institution. Indian journal of cancer 2011; 48(2): 187-93.
17. Bartlett JM, Ellis IO, Dowsett M, Mallon EA, Cameron DA, Johnston S, et al. Human epidermal growth factor receptor 2 status correlates with lymph node involvement in patients with estrogen receptor (ER) negative, but with grade in those with ER-positive earlystage breast cancer suitable for cytotoxic chemotherapy. J Clin Oncol 2007; 25(28): 4423-30.
18. Kroger N, Milde-Langosch K, Riethdorf S, Schmoor C, Schumacher M, Zander AR, et al. Prognostic and predictive effects of immunohistochemical factors in high-risk primary breast cancer patients. Clin Cancer Res 2006; 12(1): 159-68.
19. Alghanem AA, Hussain S. The effect of age on estrogen and progesterone receptor in primary breast cancer. J Surg Oncol 1985; 30(1): 29-32.
20. Dubsky PC, Gnant MF, Taucher S, Roka S, Kandioler D, Pichler-Gebhard B, et al. Young age as an independent adverse prognostic factor in premenopausal patients with breast cancer. Clin Breast Cancer 2002; 3(1): 65-72.